nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP2D6—Fingolimod—multiple sclerosis	0.104	0.189	CbGbCtD
Oxycodone—CYP3A4—Fingolimod—multiple sclerosis	0.0661	0.12	CbGbCtD
Oxycodone—CYP3A7—Dexamethasone—multiple sclerosis	0.0551	0.1	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0551	0.1	CbGbCtD
Oxycodone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0426	0.0775	CbGbCtD
Oxycodone—CYP3A5—Dexamethasone—multiple sclerosis	0.0413	0.0752	CbGbCtD
Oxycodone—CYP3A4—Triamcinolone—multiple sclerosis	0.0323	0.0587	CbGbCtD
Oxycodone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0311	0.0565	CbGbCtD
Oxycodone—CYP3A4—Betamethasone—multiple sclerosis	0.0277	0.0504	CbGbCtD
Oxycodone—CYP3A4—Prednisolone—multiple sclerosis	0.0273	0.0497	CbGbCtD
Oxycodone—CYP3A4—Prednisone—multiple sclerosis	0.0258	0.0469	CbGbCtD
Oxycodone—CYP2D6—Dexamethasone—multiple sclerosis	0.0253	0.0461	CbGbCtD
Oxycodone—CYP3A4—Dexamethasone—multiple sclerosis	0.0161	0.0293	CbGbCtD
Oxycodone—Naloxone—TLR4—multiple sclerosis	0.00465	0.708	CrCbGaD
Oxycodone—Galantamine—BCHE—multiple sclerosis	0.00134	0.204	CrCbGaD
Oxycodone—Naloxone—ALB—multiple sclerosis	0.00058	0.0884	CrCbGaD
Oxycodone—Insomnia—Prednisolone—multiple sclerosis	0.000244	0.000717	CcSEcCtD
Oxycodone—Shock—Methylprednisolone—multiple sclerosis	0.000243	0.000716	CcSEcCtD
Oxycodone—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000243	0.000714	CcSEcCtD
Oxycodone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000243	0.000713	CcSEcCtD
Oxycodone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000242	0.000713	CcSEcCtD
Oxycodone—Loss of consciousness—Betamethasone—multiple sclerosis	0.000242	0.000713	CcSEcCtD
Oxycodone—Epistaxis—Methotrexate—multiple sclerosis	0.000242	0.000712	CcSEcCtD
Oxycodone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000242	0.000712	CcSEcCtD
Oxycodone—Paraesthesia—Prednisolone—multiple sclerosis	0.000242	0.000712	CcSEcCtD
Oxycodone—Tachycardia—Triamcinolone—multiple sclerosis	0.000242	0.000712	CcSEcCtD
Oxycodone—Mental disorder—Prednisone—multiple sclerosis	0.000241	0.000711	CcSEcCtD
Oxycodone—Nausea—Azathioprine—multiple sclerosis	0.000241	0.00071	CcSEcCtD
Oxycodone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000241	0.00071	CcSEcCtD
Oxycodone—Skin disorder—Methylprednisolone—multiple sclerosis	0.00024	0.000707	CcSEcCtD
Oxycodone—Malnutrition—Prednisone—multiple sclerosis	0.00024	0.000706	CcSEcCtD
Oxycodone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00024	0.000705	CcSEcCtD
Oxycodone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000239	0.000703	CcSEcCtD
Oxycodone—Convulsion—Dexamethasone—multiple sclerosis	0.000239	0.000702	CcSEcCtD
Oxycodone—Convulsion—Betamethasone—multiple sclerosis	0.000239	0.000702	CcSEcCtD
Oxycodone—Asthenia—Mitoxantrone—multiple sclerosis	0.000236	0.000693	CcSEcCtD
Oxycodone—Myalgia—Betamethasone—multiple sclerosis	0.000235	0.00069	CcSEcCtD
Oxycodone—Myalgia—Dexamethasone—multiple sclerosis	0.000235	0.00069	CcSEcCtD
Oxycodone—Anxiety—Betamethasone—multiple sclerosis	0.000234	0.000688	CcSEcCtD
Oxycodone—Anxiety—Dexamethasone—multiple sclerosis	0.000234	0.000688	CcSEcCtD
Oxycodone—Discomfort—Dexamethasone—multiple sclerosis	0.000232	0.000682	CcSEcCtD
Oxycodone—Discomfort—Betamethasone—multiple sclerosis	0.000232	0.000682	CcSEcCtD
Oxycodone—Haemoglobin—Methotrexate—multiple sclerosis	0.000232	0.000681	CcSEcCtD
Oxycodone—Hypotension—Methylprednisolone—multiple sclerosis	0.000231	0.00068	CcSEcCtD
Oxycodone—Pain—Prednisolone—multiple sclerosis	0.00023	0.000678	CcSEcCtD
Oxycodone—Haemorrhage—Methotrexate—multiple sclerosis	0.00023	0.000678	CcSEcCtD
Oxycodone—Hepatitis—Methotrexate—multiple sclerosis	0.00023	0.000678	CcSEcCtD
Oxycodone—Pharyngitis—Methotrexate—multiple sclerosis	0.000229	0.000673	CcSEcCtD
Oxycodone—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000227	0.000669	CcSEcCtD
Oxycodone—Urethral disorder—Methotrexate—multiple sclerosis	0.000226	0.000664	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000226	0.000664	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000225	0.000663	CcSEcCtD
Oxycodone—Oedema—Dexamethasone—multiple sclerosis	0.000225	0.000662	CcSEcCtD
Oxycodone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000225	0.000662	CcSEcCtD
Oxycodone—Oedema—Betamethasone—multiple sclerosis	0.000225	0.000662	CcSEcCtD
Oxycodone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000225	0.000662	CcSEcCtD
Oxycodone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000225	0.000661	CcSEcCtD
Oxycodone—Insomnia—Triamcinolone—multiple sclerosis	0.000224	0.00066	CcSEcCtD
Oxycodone—Insomnia—Methylprednisolone—multiple sclerosis	0.000224	0.000658	CcSEcCtD
Oxycodone—Infection—Betamethasone—multiple sclerosis	0.000223	0.000657	CcSEcCtD
Oxycodone—Infection—Dexamethasone—multiple sclerosis	0.000223	0.000657	CcSEcCtD
Oxycodone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000223	0.000655	CcSEcCtD
Oxycodone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000223	0.000655	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000222	0.000653	CcSEcCtD
Oxycodone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000222	0.000653	CcSEcCtD
Oxycodone—Visual impairment—Methotrexate—multiple sclerosis	0.000222	0.000653	CcSEcCtD
Oxycodone—Anaemia—Prednisone—multiple sclerosis	0.000222	0.000653	CcSEcCtD
Oxycodone—Shock—Dexamethasone—multiple sclerosis	0.000221	0.000651	CcSEcCtD
Oxycodone—Shock—Betamethasone—multiple sclerosis	0.000221	0.000651	CcSEcCtD
Oxycodone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000221	0.00065	CcSEcCtD
Oxycodone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000221	0.000649	CcSEcCtD
Oxycodone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000221	0.000649	CcSEcCtD
Oxycodone—Agitation—Prednisone—multiple sclerosis	0.000221	0.000649	CcSEcCtD
Oxycodone—Tachycardia—Dexamethasone—multiple sclerosis	0.000219	0.000646	CcSEcCtD
Oxycodone—Tachycardia—Betamethasone—multiple sclerosis	0.000219	0.000646	CcSEcCtD
Oxycodone—Angioedema—Prednisone—multiple sclerosis	0.000219	0.000645	CcSEcCtD
Oxycodone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000218	0.000642	CcSEcCtD
Oxycodone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000218	0.00064	CcSEcCtD
Oxycodone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000217	0.00064	CcSEcCtD
Oxycodone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000217	0.00064	CcSEcCtD
Oxycodone—Malaise—Prednisone—multiple sclerosis	0.000216	0.000637	CcSEcCtD
Oxycodone—Vertigo—Prednisone—multiple sclerosis	0.000216	0.000634	CcSEcCtD
Oxycodone—Eye disorder—Methotrexate—multiple sclerosis	0.000215	0.000633	CcSEcCtD
Oxycodone—Syncope—Prednisone—multiple sclerosis	0.000215	0.000633	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—multiple sclerosis	0.000215	0.000632	CcSEcCtD
Oxycodone—Anorexia—Dexamethasone—multiple sclerosis	0.000214	0.000631	CcSEcCtD
Oxycodone—Anorexia—Betamethasone—multiple sclerosis	0.000214	0.000631	CcSEcCtD
Oxycodone—Urticaria—Prednisolone—multiple sclerosis	0.000214	0.00063	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—multiple sclerosis	0.000214	0.000629	CcSEcCtD
Oxycodone—Fatigue—Triamcinolone—multiple sclerosis	0.000214	0.000629	CcSEcCtD
Oxycodone—Fatigue—Methylprednisolone—multiple sclerosis	0.000213	0.000627	CcSEcCtD
Oxycodone—Pain—Triamcinolone—multiple sclerosis	0.000212	0.000624	CcSEcCtD
Oxycodone—Loss of consciousness—Prednisone—multiple sclerosis	0.000211	0.000621	CcSEcCtD
Oxycodone—Hypotension—Betamethasone—multiple sclerosis	0.00021	0.000618	CcSEcCtD
Oxycodone—Hypotension—Dexamethasone—multiple sclerosis	0.00021	0.000618	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—multiple sclerosis	0.000209	0.000615	CcSEcCtD
Oxycodone—Vomiting—Mitoxantrone—multiple sclerosis	0.000209	0.000615	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—multiple sclerosis	0.000208	0.000612	CcSEcCtD
Oxycodone—Convulsion—Prednisone—multiple sclerosis	0.000208	0.000612	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000208	0.000611	CcSEcCtD
Oxycodone—Rash—Mitoxantrone—multiple sclerosis	0.000207	0.000609	CcSEcCtD
Oxycodone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000207	0.000609	CcSEcCtD
Oxycodone—Chills—Methotrexate—multiple sclerosis	0.000207	0.000608	CcSEcCtD
Oxycodone—Headache—Mitoxantrone—multiple sclerosis	0.000206	0.000605	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000205	0.000603	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000205	0.000603	CcSEcCtD
Oxycodone—Arthralgia—Prednisone—multiple sclerosis	0.000204	0.000601	CcSEcCtD
Oxycodone—Myalgia—Prednisone—multiple sclerosis	0.000204	0.000601	CcSEcCtD
Oxycodone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000204	0.000601	CcSEcCtD
Oxycodone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000204	0.0006	CcSEcCtD
Oxycodone—Anxiety—Prednisone—multiple sclerosis	0.000204	0.000599	CcSEcCtD
Oxycodone—Insomnia—Dexamethasone—multiple sclerosis	0.000203	0.000598	CcSEcCtD
Oxycodone—Insomnia—Betamethasone—multiple sclerosis	0.000203	0.000598	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000203	0.000597	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000202	0.000595	CcSEcCtD
Oxycodone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000202	0.000594	CcSEcCtD
Oxycodone—Paraesthesia—Betamethasone—multiple sclerosis	0.000202	0.000594	CcSEcCtD
Oxycodone—Discomfort—Prednisone—multiple sclerosis	0.000202	0.000594	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—multiple sclerosis	0.000202	0.000594	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—multiple sclerosis	0.000201	0.00059	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000199	0.000584	CcSEcCtD
Oxycodone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000198	0.000582	CcSEcCtD
Oxycodone—Dyspepsia—Betamethasone—multiple sclerosis	0.000198	0.000582	CcSEcCtD
Oxycodone—Urticaria—Triamcinolone—multiple sclerosis	0.000197	0.000579	CcSEcCtD
Oxycodone—Urticaria—Methylprednisolone—multiple sclerosis	0.000196	0.000578	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—multiple sclerosis	0.000196	0.000578	CcSEcCtD
Oxycodone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000196	0.000576	CcSEcCtD
Oxycodone—Oedema—Prednisone—multiple sclerosis	0.000196	0.000576	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000196	0.000576	CcSEcCtD
Oxycodone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000195	0.000575	CcSEcCtD
Oxycodone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000195	0.000575	CcSEcCtD
Oxycodone—Decreased appetite—Betamethasone—multiple sclerosis	0.000195	0.000575	CcSEcCtD
Oxycodone—Nausea—Mitoxantrone—multiple sclerosis	0.000195	0.000574	CcSEcCtD
Oxycodone—Infection—Prednisone—multiple sclerosis	0.000195	0.000572	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000194	0.000571	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000194	0.000571	CcSEcCtD
Oxycodone—Back pain—Methotrexate—multiple sclerosis	0.000194	0.000571	CcSEcCtD
Oxycodone—Fatigue—Dexamethasone—multiple sclerosis	0.000194	0.00057	CcSEcCtD
Oxycodone—Fatigue—Betamethasone—multiple sclerosis	0.000194	0.00057	CcSEcCtD
Oxycodone—Shock—Prednisone—multiple sclerosis	0.000193	0.000567	CcSEcCtD
Oxycodone—Pain—Dexamethasone—multiple sclerosis	0.000192	0.000566	CcSEcCtD
Oxycodone—Pain—Betamethasone—multiple sclerosis	0.000192	0.000566	CcSEcCtD
Oxycodone—Nervous system disorder—Prednisone—multiple sclerosis	0.000192	0.000565	CcSEcCtD
Oxycodone—Tachycardia—Prednisone—multiple sclerosis	0.000191	0.000562	CcSEcCtD
Oxycodone—Skin disorder—Prednisone—multiple sclerosis	0.00019	0.00056	CcSEcCtD
Oxycodone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000189	0.000557	CcSEcCtD
Oxycodone—Anorexia—Prednisone—multiple sclerosis	0.000187	0.000549	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000186	0.000547	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—multiple sclerosis	0.000185	0.000545	CcSEcCtD
Oxycodone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000185	0.000545	CcSEcCtD
Oxycodone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000185	0.000545	CcSEcCtD
Oxycodone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000184	0.000541	CcSEcCtD
Oxycodone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000184	0.000541	CcSEcCtD
Oxycodone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000183	0.000537	CcSEcCtD
Oxycodone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000182	0.000536	CcSEcCtD
Oxycodone—Malaise—Methotrexate—multiple sclerosis	0.000181	0.000532	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—multiple sclerosis	0.00018	0.00053	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—multiple sclerosis	0.00018	0.000528	CcSEcCtD
Oxycodone—Urticaria—Dexamethasone—multiple sclerosis	0.000179	0.000526	CcSEcCtD
Oxycodone—Urticaria—Betamethasone—multiple sclerosis	0.000179	0.000526	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000178	0.000525	CcSEcCtD
Oxycodone—Dizziness—Prednisolone—multiple sclerosis	0.000178	0.000524	CcSEcCtD
Oxycodone—Asthenia—Triamcinolone—multiple sclerosis	0.000178	0.000523	CcSEcCtD
Oxycodone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000178	0.000523	CcSEcCtD
Oxycodone—Abdominal pain—Betamethasone—multiple sclerosis	0.000178	0.000523	CcSEcCtD
Oxycodone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000178	0.000523	CcSEcCtD
Oxycodone—Body temperature increased—Betamethasone—multiple sclerosis	0.000178	0.000523	CcSEcCtD
Oxycodone—Asthenia—Methylprednisolone—multiple sclerosis	0.000177	0.000522	CcSEcCtD
Oxycodone—Insomnia—Prednisone—multiple sclerosis	0.000177	0.000521	CcSEcCtD
Oxycodone—Paraesthesia—Prednisone—multiple sclerosis	0.000176	0.000517	CcSEcCtD
Oxycodone—Pruritus—Triamcinolone—multiple sclerosis	0.000175	0.000516	CcSEcCtD
Oxycodone—Cough—Methotrexate—multiple sclerosis	0.000175	0.000515	CcSEcCtD
Oxycodone—Pruritus—Methylprednisolone—multiple sclerosis	0.000175	0.000515	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—multiple sclerosis	0.000174	0.000511	CcSEcCtD
Oxycodone—Dyspepsia—Prednisone—multiple sclerosis	0.000172	0.000507	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—multiple sclerosis	0.000171	0.000502	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—multiple sclerosis	0.000171	0.000502	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—multiple sclerosis	0.000171	0.000502	CcSEcCtD
Oxycodone—Decreased appetite—Prednisone—multiple sclerosis	0.00017	0.000501	CcSEcCtD
Oxycodone—Rash—Prednisolone—multiple sclerosis	0.00017	0.0005	CcSEcCtD
Oxycodone—Dermatitis—Prednisolone—multiple sclerosis	0.00017	0.000499	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00017	0.000499	CcSEcCtD
Oxycodone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000169	0.000498	CcSEcCtD
Oxycodone—Fatigue—Prednisone—multiple sclerosis	0.000169	0.000497	CcSEcCtD
Oxycodone—Headache—Prednisolone—multiple sclerosis	0.000169	0.000497	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—multiple sclerosis	0.000169	0.000496	CcSEcCtD
Oxycodone—Constipation—Prednisone—multiple sclerosis	0.000167	0.000493	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—multiple sclerosis	0.000165	0.000486	CcSEcCtD
Oxycodone—Dizziness—Triamcinolone—multiple sclerosis	0.000164	0.000482	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000164	0.000482	CcSEcCtD
Oxycodone—Dizziness—Methylprednisolone—multiple sclerosis	0.000164	0.000481	CcSEcCtD
Oxycodone—Infection—Methotrexate—multiple sclerosis	0.000163	0.000478	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisone—multiple sclerosis	0.000161	0.000475	CcSEcCtD
Oxycodone—Asthenia—Betamethasone—multiple sclerosis	0.000161	0.000475	CcSEcCtD
Oxycodone—Asthenia—Dexamethasone—multiple sclerosis	0.000161	0.000475	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—multiple sclerosis	0.000161	0.000472	CcSEcCtD
Oxycodone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00016	0.000471	CcSEcCtD
Oxycodone—Nausea—Prednisolone—multiple sclerosis	0.00016	0.000471	CcSEcCtD
Oxycodone—Pruritus—Dexamethasone—multiple sclerosis	0.000159	0.000468	CcSEcCtD
Oxycodone—Pruritus—Betamethasone—multiple sclerosis	0.000159	0.000468	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—multiple sclerosis	0.000159	0.000468	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000158	0.000466	CcSEcCtD
Oxycodone—Vomiting—Triamcinolone—multiple sclerosis	0.000158	0.000464	CcSEcCtD
Oxycodone—Vomiting—Methylprednisolone—multiple sclerosis	0.000157	0.000463	CcSEcCtD
Oxycodone—Rash—Triamcinolone—multiple sclerosis	0.000156	0.00046	CcSEcCtD
Oxycodone—Dermatitis—Triamcinolone—multiple sclerosis	0.000156	0.000459	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—multiple sclerosis	0.000156	0.000459	CcSEcCtD
Oxycodone—Rash—Methylprednisolone—multiple sclerosis	0.000156	0.000459	CcSEcCtD
Oxycodone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000156	0.000458	CcSEcCtD
Oxycodone—Urticaria—Prednisone—multiple sclerosis	0.000156	0.000458	CcSEcCtD
Oxycodone—Headache—Triamcinolone—multiple sclerosis	0.000155	0.000457	CcSEcCtD
Oxycodone—Headache—Methylprednisolone—multiple sclerosis	0.000155	0.000456	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—multiple sclerosis	0.000155	0.000455	CcSEcCtD
Oxycodone—Body temperature increased—Prednisone—multiple sclerosis	0.000155	0.000455	CcSEcCtD
Oxycodone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000154	0.000453	CcSEcCtD
Oxycodone—Diarrhoea—Betamethasone—multiple sclerosis	0.000154	0.000453	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—multiple sclerosis	0.000153	0.00045	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000149	0.000439	CcSEcCtD
Oxycodone—Dizziness—Betamethasone—multiple sclerosis	0.000149	0.000438	CcSEcCtD
Oxycodone—Dizziness—Dexamethasone—multiple sclerosis	0.000149	0.000438	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—multiple sclerosis	0.000148	0.000436	CcSEcCtD
Oxycodone—Nausea—Triamcinolone—multiple sclerosis	0.000147	0.000433	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—multiple sclerosis	0.000147	0.000432	CcSEcCtD
Oxycodone—Nausea—Methylprednisolone—multiple sclerosis	0.000147	0.000432	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—multiple sclerosis	0.000146	0.000429	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—multiple sclerosis	0.000145	0.000428	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisone—multiple sclerosis	0.000144	0.000425	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—multiple sclerosis	0.000144	0.000424	CcSEcCtD
Oxycodone—Vomiting—Dexamethasone—multiple sclerosis	0.000143	0.000421	CcSEcCtD
Oxycodone—Vomiting—Betamethasone—multiple sclerosis	0.000143	0.000421	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—multiple sclerosis	0.000142	0.000419	CcSEcCtD
Oxycodone—Rash—Betamethasone—multiple sclerosis	0.000142	0.000417	CcSEcCtD
Oxycodone—Rash—Dexamethasone—multiple sclerosis	0.000142	0.000417	CcSEcCtD
Oxycodone—Dermatitis—Dexamethasone—multiple sclerosis	0.000142	0.000417	CcSEcCtD
Oxycodone—Dermatitis—Betamethasone—multiple sclerosis	0.000142	0.000417	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000141	0.000416	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—multiple sclerosis	0.000141	0.000415	CcSEcCtD
Oxycodone—Headache—Betamethasone—multiple sclerosis	0.000141	0.000414	CcSEcCtD
Oxycodone—Headache—Dexamethasone—multiple sclerosis	0.000141	0.000414	CcSEcCtD
Oxycodone—Asthenia—Prednisone—multiple sclerosis	0.000141	0.000413	CcSEcCtD
Oxycodone—Pain—Methotrexate—multiple sclerosis	0.00014	0.000412	CcSEcCtD
Oxycodone—Pruritus—Prednisone—multiple sclerosis	0.000139	0.000408	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000135	0.000397	CcSEcCtD
Oxycodone—Diarrhoea—Prednisone—multiple sclerosis	0.000134	0.000394	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000134	0.000394	CcSEcCtD
Oxycodone—Nausea—Betamethasone—multiple sclerosis	0.000134	0.000393	CcSEcCtD
Oxycodone—Nausea—Dexamethasone—multiple sclerosis	0.000134	0.000393	CcSEcCtD
Oxycodone—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000131	0.00127	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000131	0.00127	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000131	0.00126	CbGpPWpGaD
Oxycodone—Urticaria—Methotrexate—multiple sclerosis	0.00013	0.000383	CcSEcCtD
Oxycodone—Dizziness—Prednisone—multiple sclerosis	0.00013	0.000381	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—multiple sclerosis	0.000129	0.000381	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—multiple sclerosis	0.000129	0.000381	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.000129	0.00124	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000129	0.00124	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000128	0.00123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.000126	0.00121	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000126	0.00121	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000125	0.00121	CbGpPWpGaD
Oxycodone—Vomiting—Prednisone—multiple sclerosis	0.000125	0.000366	CcSEcCtD
Oxycodone—Rash—Prednisone—multiple sclerosis	0.000123	0.000363	CcSEcCtD
Oxycodone—Dermatitis—Prednisone—multiple sclerosis	0.000123	0.000363	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000123	0.00119	CbGpPWpGaD
Oxycodone—Headache—Prednisone—multiple sclerosis	0.000123	0.000361	CcSEcCtD
Oxycodone—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000122	0.00118	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—POMC—multiple sclerosis	0.000122	0.00118	CbGpPWpGaD
Oxycodone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000121	0.000355	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000119	0.00115	CbGpPWpGaD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000118	0.00114	CbGpPWpGaD
Oxycodone—Asthenia—Methotrexate—multiple sclerosis	0.000117	0.000345	CcSEcCtD
Oxycodone—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000117	0.00113	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000117	0.00113	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000116	0.00112	CbGpPWpGaD
Oxycodone—Nausea—Prednisone—multiple sclerosis	0.000116	0.000342	CcSEcCtD
Oxycodone—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000116	0.00112	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.000116	0.00112	CbGpPWpGaD
Oxycodone—Pruritus—Methotrexate—multiple sclerosis	0.000116	0.000341	CcSEcCtD
Oxycodone—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.000115	0.00111	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000115	0.00111	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000113	0.00109	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000113	0.00109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000112	0.00108	CbGpPWpGaD
Oxycodone—Diarrhoea—Methotrexate—multiple sclerosis	0.000112	0.000329	CcSEcCtD
Oxycodone—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000112	0.00108	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000111	0.00107	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000111	0.00107	CbGpPWpGaD
Oxycodone—Dizziness—Methotrexate—multiple sclerosis	0.000108	0.000318	CcSEcCtD
Oxycodone—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000108	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000106	0.00102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000106	0.00102	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000104	0.00101	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000104	0.00101	CbGpPWpGaD
Oxycodone—Vomiting—Methotrexate—multiple sclerosis	0.000104	0.000306	CcSEcCtD
Oxycodone—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000104	0.001	CbGpPWpGaD
Oxycodone—Rash—Methotrexate—multiple sclerosis	0.000103	0.000304	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—multiple sclerosis	0.000103	0.000303	CcSEcCtD
Oxycodone—Headache—Methotrexate—multiple sclerosis	0.000103	0.000302	CcSEcCtD
Oxycodone—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000102	0.000985	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000102	0.000984	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000102	0.00098	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000102	0.00098	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.000101	0.000971	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	9.83e-05	0.000948	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	9.79e-05	0.000944	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	9.76e-05	0.000941	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	9.73e-05	0.000939	CbGpPWpGaD
Oxycodone—Nausea—Methotrexate—multiple sclerosis	9.72e-05	0.000286	CcSEcCtD
Oxycodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.55e-05	0.000921	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SRM—multiple sclerosis	9.55e-05	0.000921	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	9.54e-05	0.00092	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	9.49e-05	0.000915	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	9.49e-05	0.000915	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	9.38e-05	0.000905	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	9.31e-05	0.000898	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	9.31e-05	0.000898	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	9.25e-05	0.000892	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	9.23e-05	0.00089	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	9.16e-05	0.000884	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	9.06e-05	0.000874	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	8.95e-05	0.000863	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	8.91e-05	0.00086	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	8.86e-05	0.000855	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—POMC—multiple sclerosis	8.85e-05	0.000853	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	8.82e-05	0.00085	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	8.63e-05	0.000832	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	8.62e-05	0.000831	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	8.59e-05	0.000829	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	8.56e-05	0.000825	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	8.52e-05	0.000822	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPC5—multiple sclerosis	8.51e-05	0.000821	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	8.51e-05	0.000821	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	8.46e-05	0.000816	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	8.46e-05	0.000816	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	8.45e-05	0.000815	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	8.32e-05	0.000803	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	8.28e-05	0.000798	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	8.23e-05	0.000793	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	8.11e-05	0.000783	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	8.09e-05	0.000781	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	8.02e-05	0.000773	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	7.94e-05	0.000766	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	7.77e-05	0.00075	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.74e-05	0.000747	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	7.74e-05	0.000747	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	7.67e-05	0.00074	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	7.56e-05	0.00073	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	7.53e-05	0.000727	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	7.47e-05	0.000721	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	7.42e-05	0.000716	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	7.42e-05	0.000716	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	7.41e-05	0.000714	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	7.28e-05	0.000702	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	7.27e-05	0.000701	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	7.23e-05	0.000698	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—RRM1—multiple sclerosis	7.05e-05	0.00068	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	7.03e-05	0.000678	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	6.95e-05	0.000671	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	6.86e-05	0.000661	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	6.84e-05	0.00066	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SRM—multiple sclerosis	6.79e-05	0.000655	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	6.73e-05	0.000649	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	6.73e-05	0.000649	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	6.73e-05	0.000649	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	6.71e-05	0.000648	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	6.6e-05	0.000637	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	6.57e-05	0.000634	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	6.55e-05	0.000632	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	6.46e-05	0.000623	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	6.38e-05	0.000615	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	6.31e-05	0.000609	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	6.29e-05	0.000607	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	6.27e-05	0.000605	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	6.27e-05	0.000605	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	6.26e-05	0.000604	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPC5—multiple sclerosis	6.15e-05	0.000593	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	6.03e-05	0.000582	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	5.95e-05	0.000574	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	5.86e-05	0.000565	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	5.8e-05	0.00056	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	5.79e-05	0.000558	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	5.74e-05	0.000554	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PGR—multiple sclerosis	5.72e-05	0.000551	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	5.68e-05	0.000548	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	5.66e-05	0.000546	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	5.61e-05	0.000541	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CD28—multiple sclerosis	5.55e-05	0.000536	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	5.45e-05	0.000526	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	5.39e-05	0.00052	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	5.29e-05	0.00051	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	5.22e-05	0.000503	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	5.14e-05	0.000496	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	5.12e-05	0.000494	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—RRM1—multiple sclerosis	5.1e-05	0.000492	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	5.09e-05	0.000491	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	5.03e-05	0.000485	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PGR—multiple sclerosis	5.01e-05	0.000483	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	4.92e-05	0.000474	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	4.89e-05	0.000472	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CD28—multiple sclerosis	4.87e-05	0.00047	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	4.85e-05	0.000468	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	4.78e-05	0.000461	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.78e-05	0.000461	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.78e-05	0.000461	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	4.78e-05	0.000461	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	4.65e-05	0.000448	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	4.55e-05	0.000439	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	4.53e-05	0.000437	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	4.49e-05	0.000433	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	4.47e-05	0.000431	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SRM—multiple sclerosis	4.44e-05	0.000428	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	4.41e-05	0.000426	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	4.41e-05	0.000425	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.37e-05	0.000422	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	4.34e-05	0.000419	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	4.3e-05	0.000415	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PGR—multiple sclerosis	4.24e-05	0.000409	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	4.15e-05	0.000401	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	4.13e-05	0.000398	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CD28—multiple sclerosis	4.12e-05	0.000397	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.11e-05	0.000397	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	4.08e-05	0.000393	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—BCHE—multiple sclerosis	4.05e-05	0.000391	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	4.04e-05	0.00039	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	3.99e-05	0.000385	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	3.97e-05	0.000383	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CD86—multiple sclerosis	3.96e-05	0.000382	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	3.9e-05	0.000376	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	3.79e-05	0.000366	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	3.78e-05	0.000365	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	3.73e-05	0.00036	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.63e-05	0.00035	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	3.62e-05	0.000349	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	3.61e-05	0.000348	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	3.51e-05	0.000339	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CD86—multiple sclerosis	3.47e-05	0.000335	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	3.46e-05	0.000334	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	3.45e-05	0.000332	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	3.44e-05	0.000332	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	3.42e-05	0.00033	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	3.37e-05	0.000325	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	3.36e-05	0.000324	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	3.32e-05	0.00032	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APOE—multiple sclerosis	3.2e-05	0.000308	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	3.17e-05	0.000306	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.13e-05	0.000302	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.13e-05	0.000302	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	3.08e-05	0.000297	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	3.06e-05	0.000295	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	3.04e-05	0.000293	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	3.01e-05	0.000291	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CD86—multiple sclerosis	2.94e-05	0.000283	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.93e-05	0.000282	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	2.89e-05	0.000279	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CD80—multiple sclerosis	2.89e-05	0.000279	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.86e-05	0.000276	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.8e-05	0.000271	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOE—multiple sclerosis	2.8e-05	0.00027	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—POMC—multiple sclerosis	2.75e-05	0.000265	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	2.69e-05	0.000259	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	2.68e-05	0.000258	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	2.63e-05	0.000254	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	2.6e-05	0.000251	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.57e-05	0.000248	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	2.55e-05	0.000246	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CD80—multiple sclerosis	2.53e-05	0.000244	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	2.44e-05	0.000235	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOE—multiple sclerosis	2.44e-05	0.000235	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—POMC—multiple sclerosis	2.41e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.37e-05	0.000229	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOE—multiple sclerosis	2.37e-05	0.000229	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	2.36e-05	0.000227	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	2.31e-05	0.000222	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CD80—multiple sclerosis	2.14e-05	0.000207	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	2.14e-05	0.000206	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—POMC—multiple sclerosis	2.09e-05	0.000202	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.08e-05	0.000201	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—POMC—multiple sclerosis	2.04e-05	0.000196	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—multiple sclerosis	2.03e-05	0.000196	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	2.02e-05	0.000195	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	1.99e-05	0.000192	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.95e-05	0.000188	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	1.92e-05	0.000185	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—multiple sclerosis	1.91e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	1.81e-05	0.000174	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—multiple sclerosis	1.78e-05	0.000172	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	1.77e-05	0.000171	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOE—multiple sclerosis	1.76e-05	0.00017	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	1.71e-05	0.000165	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	1.68e-05	0.000163	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—multiple sclerosis	1.59e-05	0.000153	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	1.58e-05	0.000153	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	1.55e-05	0.00015	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—POMC—multiple sclerosis	1.51e-05	0.000146	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—multiple sclerosis	1.5e-05	0.000145	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	1.5e-05	0.000145	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	1.5e-05	0.000144	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	1.42e-05	0.000137	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—multiple sclerosis	1.39e-05	0.000134	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	1.39e-05	0.000134	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—multiple sclerosis	1.38e-05	0.000133	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	1.36e-05	0.000131	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.36e-05	0.000131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	1.27e-05	0.000122	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOE—multiple sclerosis	1.25e-05	0.000121	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—multiple sclerosis	1.19e-05	0.000115	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—multiple sclerosis	1.18e-05	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.17e-05	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.15e-05	0.000111	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—POMC—multiple sclerosis	1.08e-05	0.000104	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—multiple sclerosis	1.05e-05	0.000101	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—multiple sclerosis	9.81e-06	9.46e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—multiple sclerosis	8.84e-06	8.53e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOE—multiple sclerosis	8.19e-06	7.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—POMC—multiple sclerosis	7.04e-06	6.79e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—multiple sclerosis	6.41e-06	6.19e-05	CbGpPWpGaD
